Amniotics AB is a biotechnology company based in Lund, Sweden. The organization specializes in the development of innovative therapies and products derived from amniotic fluid and tissue. Their research focuses on harnessing the regenerative properties of amniotic material to create solutions for various medical conditions, particularly in the fields of orthopedics and wound healing.
The company is involved in the entire process of product development, from initial research and development to clinical trials and commercialization. Amniotics AB aims to address unmet medical needs by providing advanced treatment options that leverage the unique biological characteristics of amniotic fluid. Their work contributes to the growing field of regenerative medicine, which seeks to repair or replace damaged tissues and organs.